Clinical Cardiology in a New Era: Navigating Challenges and Embracing Opportunities

Dear Colleagues,

The realm of cardiovascular medicine is witnessing an unprecedented pace of evolution, characterized by continual breakthroughs in technologies, diagnostic methodologies, and therapeutic interventions. Novel devices and therapeutic strategies are incessantly introduced, altering the landscape and extending the scope of cardiology subspecialties.

Amid this rapid metamorphosis, we have observed the emergence of novel subspecialties, alterations in patient roles, and modifications in payment models, all of which have led to myriad challenges and, simultaneously, bountiful opportunities within the domain.

The approach to cardiology has transitioned from individual decision making to a heart-team-based practice. This paradigm necessitates an extensive amount of coordination and a multidisciplinary approach, seeing as multiple subspecialties may interface with a single patient. Concurrently, the significant overlap and increasing complexity of these subspecialties have engendered the creation of new areas of focus and specialization, necessitating the continual evolution of training paths to align with the dynamic needs of the field.

The escalation in the prevalence of cardiovascular disease, exacerbated by an aging population, has augmented the associated costs. In the USA, cardiovascular diseases and stroke incur an estimated annual cost of USD 316.6 billion, with projections indicating that over 40% of the population will be afflicted by cardiovascular disease by 2030. A similar scenario is unfolding in Europe, where cardiovascular diseases account for 47% of all deaths and impose an estimated annual economic burden of nearly EUR 196 billion. As the complexity and costs of cardiovascular care escalate, it is imperative that therapeutic decision making incorporates evaluations of efficacy, effectiveness, and rigorous cost–benefit and cost–effectiveness analyses.

Historically marginalized populations continue to experience disproportionately elevated rates of cardiovascular diseases and associated risk factors. Despite the demonstrated efficacy of evidence-based practices in enhancing outcomes, these populations encounter the most significant barriers to accessing these advanced practices. To ameliorate overall population health, it is crucial to bridge this disparity and establish pathways to facilitate cardiovascular health equity.

Recognizing the intricacies and the continual evolution endemic to cardiovascular medicine, Medicina is honored to announce the launch of a Special Issue titled “Clinical Cardiology in a New Era: Navigating Challenges and Embracing Opportunities”. This Special Issue seeks to collect insights from eminent experts across diverse subspecialties to delve into the multifaceted, transformative, and rapidly progressing field of cardiovascular medicine and the shifting healthcare landscape, thereby outlining prospective pathways for this domain.

We extend a warm invitation to you and your distinguished colleagues to contribute your original manuscripts to this journal, aiding in the illumination of the diverse and rapidly advancing dimensions of cardiovascular medicine.

Dr. Rayan Yousefzai
Prof. Dr. Cindy M. Martin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiovascular medicine
• cardiology subspeciality
• cardiomyopathy

My idea is to have a brief previous, new development and the future of each field:
•             Interventional cardiology
•             Electrophysiology
•             Heart failure
•             Advanced heart failure
•             Adult Congenital heart disease
•             Cardiology Imaging
Also, the new focused subspecialty that has been born recently
•             Structural/valve interventional
•             Structural/Interventional Imaging
•             Heart failure/Adult Congenital Heart Disease
•             Heart failure/Structural
•             Genetic Cardiology
•             Cardio-oncology
•             Adult Congenital transplant
 
Some other topics:

•             Artificial Intelligence in cardiology
•             Infiltrative Cardiomyopathy (amyloidosis and sarcoidosis
•             New devices in heart failure management
•             Cardiogenic shock/Mechanical circulatory support/shock team
•             Right ventricular failure and pulmonary hypertension
•             Translational research